IRCT2017073022965N12
Recruiting
Phase 3
evaluation of the effect of oral N-acetylcysteine on nitrosative stress factors in patients with rheumatoid arthritis
Vice Chancellor for research of Hamadan University of Medical Sciences0 sites52 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Vice Chancellor for research of Hamadan University of Medical Sciences
- Enrollment
- 52
- Status
- Recruiting
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •inclusion criteria: Patients with active rheumatoid arthritis; Normal renal function(serum creatinine lower than 2\); Ability of taking oral n\-acetylcysteine; Normal liver function
- •exclusion criteria: Renal dysfunction; Liver dysfunction; Active infection; Mental or cognitive problem; Disability of taking oral drug; Taking antioxidant agents or anti\-inflammatory drugs in previous month; Patients with other inflammatory diseases; Patients whom experience adverse drug reactions; Pregnant or lactating patients
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
The effect of oral N-acetylcysteine on quantitative serum high sensitivity CRP and hemoglobin in hemodialysis patientsEnd stage renal disease.End stage kidney diseaseN 18.5IRCT2016111030821N1Vice Chancellor for research of Ardabil University of Medical Sciences40
Recruiting
Phase 3
Evaluation of oral N-acetylcysteine efficacy versus placebo in prevention of mucositis induced by radiotherapy and chemotherapy agents in children with malignancyIRCT20210622051666N1Ahvaz University of Medical Sciences80
Completed
Phase 2
Evaluating the effects of oral N-acetyl cysteine as an adjuvant therapy for pain management and serum level of oxidative stress bio-markers in patients with painful diabetic neuropathyDiabetic polyneuropathy.Type 2 diabetes mellitus with diabetic polyneuropathyE11.42IRCT20150629022965N19Hamedan University of Medical Sciences140
Completed
Phase 2
Effect of N-acetyl cysteine on controling clinical symtoms and inflammatory biomarkers in rhumatoid arthritis PatientsRheumatoid arthritis.Rheumatoid arthritis, unspecifiedIRCT2015071722965N2Vice chancellor for research, Hamadan University of Medical Sciences70
Recruiting
Phase 2
Oral N-acetylcysteine (NAC) effectiveness in cystic fibrosis (CF)IRCT20090808002306N7Esfahan University of Medical Sciences45